JP2021512921A5 - - Google Patents
Info
- Publication number
- JP2021512921A5 JP2021512921A5 JP2020542862A JP2020542862A JP2021512921A5 JP 2021512921 A5 JP2021512921 A5 JP 2021512921A5 JP 2020542862 A JP2020542862 A JP 2020542862A JP 2020542862 A JP2020542862 A JP 2020542862A JP 2021512921 A5 JP2021512921 A5 JP 2021512921A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical product
- administered
- product according
- day
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862629579P | 2018-02-12 | 2018-02-12 | |
| US62/629,579 | 2018-02-12 | ||
| PCT/US2019/017430 WO2019157423A1 (en) | 2018-02-12 | 2019-02-11 | Methods and dosing regimens using ibudilast and a second agent for cancer therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021512921A JP2021512921A (ja) | 2021-05-20 |
| JP2021512921A5 true JP2021512921A5 (https=) | 2022-02-17 |
Family
ID=67542181
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020542862A Pending JP2021512921A (ja) | 2018-02-12 | 2019-02-11 | 癌療法に対するイブジラストおよび第二の薬剤を使用した方法ならびに投与レジメン |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US10744123B2 (https=) |
| EP (1) | EP3752147A4 (https=) |
| JP (1) | JP2021512921A (https=) |
| CN (1) | CN112236140A (https=) |
| CA (1) | CA3090884A1 (https=) |
| WO (1) | WO2019157423A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021512921A (ja) * | 2018-02-12 | 2021-05-20 | メディシノバ・インコーポレイテッドＭｅｄｉｃｉＮｏｖａ， Ｉｎｃ． | 癌療法に対するイブジラストおよび第二の薬剤を使用した方法ならびに投与レジメン |
| US12005049B2 (en) | 2021-07-26 | 2024-06-11 | Medicinova, Inc. | Methods of preventing cancer metastasis |
| CN113584172B (zh) * | 2021-08-04 | 2022-08-02 | 中南大学湘雅二医院 | Slc12a5及其抑制剂的应用 |
| CA3231869A1 (en) * | 2021-09-21 | 2023-03-30 | Medicinova, Inc. | Ibudilast in combination therapy for use in the treatment of glioblastoma |
| US12042485B2 (en) | 2021-10-07 | 2024-07-23 | Medicinova, Inc. | Methods of minimizing cancer metastasis |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6395747B1 (en) | 1998-08-10 | 2002-05-28 | Sauro Sakoda | Remedies for multiple sclerosis |
| JP4954085B2 (ja) | 2004-12-06 | 2012-06-13 | メディシノバ， インコーポレイテッド | 神経障害性疼痛及びその関連する症状を治療するためのイブジラスト |
| TW200716141A (en) * | 2005-05-05 | 2007-05-01 | Combinatorx Inc | Compositions and methods for treatment for neoplasms |
| US8138201B2 (en) | 2007-07-11 | 2012-03-20 | Medicinova, Inc. | Treatment of progressive neurodegenerative disease with ibudilast |
| EP2804602B1 (en) * | 2012-01-20 | 2024-12-04 | Del Mar Pharmaceuticals | Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem cells including glioblastoma multforme and medulloblastoma |
| WO2016201354A1 (en) | 2015-06-11 | 2016-12-15 | Globavir Biosciences, Inc. | Methods and compositions for treating cancer |
| WO2018119262A1 (en) * | 2016-12-22 | 2018-06-28 | Medicinova, Inc. | Methods of treating glioblastoma multiforme using ibudilast |
| JP2021512921A (ja) * | 2018-02-12 | 2021-05-20 | メディシノバ・インコーポレイテッドＭｅｄｉｃｉＮｏｖａ， Ｉｎｃ． | 癌療法に対するイブジラストおよび第二の薬剤を使用した方法ならびに投与レジメン |
-
2019
- 2019-02-11 JP JP2020542862A patent/JP2021512921A/ja active Pending
- 2019-02-11 EP EP19751704.8A patent/EP3752147A4/en not_active Withdrawn
- 2019-02-11 CN CN201980022054.9A patent/CN112236140A/zh active Pending
- 2019-02-11 US US16/272,694 patent/US10744123B2/en active Active
- 2019-02-11 CA CA3090884A patent/CA3090884A1/en active Pending
- 2019-02-11 WO PCT/US2019/017430 patent/WO2019157423A1/en not_active Ceased
-
2020
- 2020-07-10 US US16/926,441 patent/US11446283B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021512921A5 (https=) | ||
| CA2856646C (en) | Combination treatment of cancer | |
| JP2015512406A5 (https=) | ||
| JP2018520189A5 (https=) | ||
| TW200914011A (en) | Therapeutic compositions and methods | |
| TW200916103A (en) | Therapeutic compositions and methods | |
| CA3034875C (en) | Combination therapies for the treatment of hepatocellular carcinoma | |
| JP2009517411A5 (https=) | ||
| CN113784717A (zh) | 一种治疗肺动脉高压和相关性肺动脉高压的方法以及每日给药 | |
| JP2019507786A5 (https=) | ||
| TWI606826B (zh) | 艾拉莫德或其鹽之用途 | |
| CN120713908A (zh) | 帕布昔利布在黏膜恶性黑色素瘤中的应用 | |
| JP2021535163A5 (https=) | ||
| CA2986359A1 (en) | Pharmaceutical combination of everolimus with dactolisib | |
| CA2684174C (fr) | Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo-pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des desordres moteurs lies a la maladie de parkinson | |
| AU2007234917B2 (en) | Renin inhibitors for the treatment of hypertension | |
| JP2023531930A5 (https=) | ||
| JPH0359044B2 (https=) | ||
| CN115607545B (zh) | 依达拉奉在自闭症谱系障碍治疗中的应用 | |
| JP2022512158A5 (https=) | ||
| JP2021091608A5 (https=) | ||
| CN115279367B (zh) | 用于治疗细胞因子风暴和细胞因子释放综合征的组合物和方法 | |
| JP2024543347A5 (https=) | ||
| JPWO2024241468A5 (https=) | ||
| CN114340672B (zh) | 包含hdac抑制剂和抗pd1抗体或抗pd-l1抗体的药物组合物 |